Still in a 6 month downtrend/consolidation. Exciting times ahead when we break out!

I could see how someone uneducated about bitcoin would think it’s a scam. Market crashes is an opportunity. There have been so many in the past it’s nothing to worry about if your portfolio is balanced across different sectors.

It was a post for laughs. I'm bullish on bitcoin. It has the largest network of users including companies, wall st., and bankers. If you think about the order of technology. We have one of the greatest inventions the Internet. Here we are a little over 30 years and it's usage is peaked. Then we had the smart phone which is nearing 18 years and it's usage has peaked. So now we have bitcoin and anyone with internet and smart phone can have access to bitcoin. So I googled how many smart phones are in use. How much longer till bitcoin hits it's peak users? We maybe have 200 million people that own some bitcoin. We are still early...

This is an obvious bull trap before it heads to $0

Agree. He's lining my pockets as well.

Voted out but bod says he should stay. That's some corrupt sht right there. Unbelievable

Hey Fung, still here. It's been like 3-4 years since I been here. What a run that was...

This one just takes patience. But its going 100% from here eventually.

Making an exit at a loss. This was a disaster lol.

Acquisition offer? Old news..we heard it first from JeanFM lol.

I bought 1 share back in 2021 just to keep track. It is -89%

What phase are they in? How much cash on hand do they have? What is their quarterly burn rate? I'll look up answers to these questions when I have time.

Why did the OS more than triple from 25M to its current 94M in 6 months.
2024-06-30 94,000,000
2024-03-31 35,000,000
2023-12-31 25,000,000
2023-09-30 33,000,000
2023-06-30 15,000,000
2023-03-31 15,000,000
2022-12-31 15,000,000
2022-09-30 15,000,000

Holding nothing. This management is Terrible. They will need to raise funds within 8 months further diluting shareholders. They burn nearly $40 million a quarter. The money they're getting from the sale will not last long. SER-155 will be a specialty drug which equals little revenue if it even makes it that far. This is just my opinion and I have been wrong many times. Good luck if you are holding.

Wow lol. -9% nice share grab by tutes.

Agree. What's bad is there are people trying to pump it. What's worse is the SEC lets the company remain on the market.

The real catalyst is revenue IMO. They're at $119M revenue in just two quarters for 2024. If Q3 stuns again, we might be close to $300M this year!

IMO 5/6 bucks...is a good reentry point. Xphozah Q2 revenue already surpassed Ibsrela and it's only be on the market for about 2.5 quarters. Market cap is sitting at $1.4B. Just need a little patience on this one, they can't keep the price suppressed for too long. I think Q3 ER (2 months) will be the tipping point if the share price doesn't rise by then. They can't hold it down if the number are even greater than Q2.

Company ends Q2 with approximately $186 million in cash and investments
IBSRELA® (tenapanor) records $35.4 million in net product sales revenue in Q2 2024
XPHOZAH® (tenapanor) launch progresses, records $37.1 million net product sales revenue during Q2 2024
Revenues: Total revenue for the quarter ended June 30, 2024 was $73.2 million

$22 ohh bwahaha 🤣

So basically you agree that this company is trash lol.

This has been a good 6 months of consolidation. What a massive run its been on since January of 2023!

Price manipulation. Look back to October 18, 2023; we traded nearly 58,000,000 shares the day after Xphozah was FDA approved. I think MM's and Broker's colluded. Parked and Bundled retail orders on darkpool. . The price didnt move. Only started climbing a month later in November then went on a bull run for the next two months into January 2024. But this rise came with normal volume as they let orders flow to lit exchanges. Then price targets got raised and they dumped on retail $9 - $10.

But this is speculation and just my opinion and a scenario that I made up in my head. I needed something to justify the large volume with no price movement and the small volume and large price movement. Anyone have a better theory? I would love to hear it.

So after the 2024 Q2 ER, and seeing the excellent sales revenue. Watched the price action tickle just over $6 and drop back down to $5's. It appears the same thing is happening again. I have already added back all the shares I sold back in December/January. And still increasing position to an even larger position than I had before.

I thought you sold everything and the only way your buying back in is if the price drops below $1.13

omg, that article regarding TNX-1300 cracked me up! That is hilarious. This company is a joke...

Completely agree with you on this

Why would anyone buy stock in this company. With ETFs that track the asset it makes this company irrelevant. This whole company can go down and there will be plenty of miners to keep the network safe. Miners are dime a dozen.

Reduced position to 15% of original holding. Average profit of 40%, taking the win. Management makes this company risky!

They smashed estimates again! Wow! Very impressive.

The day I bought this the float exploded lol

ARDX Reporting on a day market is getting throttled.

Thanks for info. Now I clearly see why they want no part in that bundle.

Still here holding my bags. This tunnel is long and dark, let there be light!

Exited another 10% of position. Taking some off the table just in case...

What's the political motive or who does this benefit by the act passing.

Bought the dip at $1.10 the other day and sold that today and %5 more of my core position. Will start another position if it dips again.

We all new this would eventually pay off!

The past few days have been great! Sold off 15% of my position today. Taking some off the table for profits.

In my opinion management read through the policy and realized it is not best for the company. And at the rate Xphozah is being prescribed, I believe they are correct. The sales last quarter smashed through expectations.

Ardelyx said its analysis of the CMS policy to include oral-only medicines in the PPS and the calendar year 2025 ESRD PPS Proposed Rule released on June 27, revealed that the policy and the manner in which CMS intends to implement it are likely to cause significant restrictions on the use of XPHOZAH for all patients because it interferes with the essential and appropriate shared decision-making between healthcare professionals and their patients.
From Erica Kollman article.

I shot those numbers out of my A55 lol. But you get the picture. Even if its flat at $150M for year 2025, to trade at $300M market cap is highly unlikely. I think from here it will see 50 - 100% gain within a few months. Good luck

So you're waiting for the market cap to go $300M, which is basically what their revenue will probably be next year? That doesn't make sense to me. I don't think this will go down another 80% from here. That would put the share price at pre Xphozah approval in 2022. I guess we will agree to disagree here.